Allogene Therapeutics, Inc.
Machine-extracted from this filing. Every card cites the SEC source. See all recent executive movements.
On April 19, 2023, the Company’s Board of Directors appointed Tim Moore to serve as Chief Technical Officer, effective April 24, 2023.
On April 18, 2023, Alison Moore, the Chief Technical Officer of Allogene Therapeutics, Inc. (the “Company”), notified the Company of her decision to resign effective April 28, 2023 to pursue other opportunities.
Extracted from this filing and checked against the source text.
Tim Moore was appointed as Chief Technical Officer at Allogene Therapeutics, Inc..
On April 19, 2023, the Company’s Board of Directors appointed Tim Moore to serve as Chief Technical Officer, effective April 24, 2023.View on SEC.gov
Alison Moore resigned as Chief Technical Officer at Allogene Therapeutics, Inc..
On April 18, 2023, Alison Moore, the Chief Technical Officer of Allogene Therapeutics, Inc. (the “Company”), notified the Company of her decision to resign effective April 28, 2023 to pursue other opportunities.View on SEC.gov
This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.